PortfoliosLab logoPortfoliosLab logo
BHC vs. VTRS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BHC vs. VTRS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bausch Health Companies Inc. (BHC) and Viatris Inc. (VTRS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BHC achieves a -32.81% return, which is significantly lower than VTRS's 25.50% return.


BHC

1D
-2.10%
1M
-14.63%
YTD
-32.81%
6M
-33.19%
1Y
-24.43%
3Y*
-13.40%
5Y*
-30.63%
10Y*
-13.65%

VTRS

1D
0.07%
1M
-7.63%
YTD
25.50%
6M
30.10%
1Y
80.23%
3Y*
21.50%
5Y*
6.02%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BHC vs. VTRS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
BHC
Bausch Health Companies Inc.
-32.81%-13.77%0.50%27.71%-77.25%32.74%6.12%
VTRS
Viatris Inc.
25.50%5.08%19.68%2.06%-14.29%-26.12%19.82%

Correlation

The correlation between BHC and VTRS is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.36

Correlation (3Y)
Calculated over the trailing 3-year period

0.33

Correlation (5Y)
Calculated over the trailing 5-year period

0.39

Correlation (All Time)
Calculated using the full available price history since Nov 16, 2020

0.38

Fundamentals

EPS

BHC:

-$4.32

VTRS:

-$0.25

PS Ratio

BHC:

0.12

VTRS:

1.23

Total Revenue (TTM)

BHC:

$10.55B

VTRS:

$14.56B

Gross Profit (TTM)

BHC:

$7.97B

VTRS:

$5.01B

EBITDA (TTM)

BHC:

$1.41B

VTRS:

$1.89B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BHC vs. VTRS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BHC
BHC Risk / Return Rank: 2121
Overall Rank
BHC Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
BHC Sortino Ratio Rank: 1919
Sortino Ratio Rank
BHC Omega Ratio Rank: 2121
Omega Ratio Rank
BHC Calmar Ratio Rank: 2222
Calmar Ratio Rank
BHC Martin Ratio Rank: 2222
Martin Ratio Rank

VTRS
VTRS Risk / Return Rank: 9191
Overall Rank
VTRS Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
VTRS Sortino Ratio Rank: 9292
Sortino Ratio Rank
VTRS Omega Ratio Rank: 9191
Omega Ratio Rank
VTRS Calmar Ratio Rank: 9090
Calmar Ratio Rank
VTRS Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BHC vs. VTRS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bausch Health Companies Inc. (BHC) and Viatris Inc. (VTRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BHCVTRSDifference
Sharpe ratioReturn per unit of total volatility

-3.00

Sortino ratioReturn per unit of downside risk

-3.98

Omega ratioGain probability vs. loss probability

0.94

1.43

-0.49

Calmar ratioReturn relative to maximum drawdown

-0.56

4.25

-4.81

Martin ratioReturn relative to average drawdown

-0.96

11.93

-12.88

BHC vs. VTRS - Sharpe Ratio Comparison

The current BHC Sharpe Ratio is -0.51, which is lower than the VTRS Sharpe Ratio of 2.49. The chart below compares the historical Sharpe Ratios of BHC and VTRS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BHC vs. VTRS - Drawdown Comparison

The maximum BHC drawdown since its inception was -98.35%, which is greater than VTRS's maximum drawdown of -54.33%. Use the drawdown chart below to compare losses from any high point for BHC and VTRS.


Loading charts...

Drawdown Indicators


BHCVTRSDifference

Max Drawdown

Largest peak-to-trough decline

-98.35%

-54.33%

-44.02%

Max Drawdown (1Y)

Largest decline over 1 year

-44.00%

-18.97%

-25.03%

Max Drawdown (3Y)

Largest decline over 3 years

-59.28%

-45.02%

-14.26%

Max Drawdown (5Y)

Largest decline over 5 years

-85.63%

-45.69%

-39.94%

Max Drawdown (10Y)

Largest decline over 10 years

-87.43%

Current Drawdown

Current decline from peak

-98.22%

-10.91%

-87.31%

Average Drawdown

Average peak-to-trough decline

-60.93%

-30.66%

-30.27%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.59%

6.75%

+18.84%

Volatility

BHC vs. VTRS - Volatility Comparison

Bausch Health Companies Inc. (BHC) has a higher volatility of 11.32% compared to Viatris Inc. (VTRS) at 7.88%. This indicates that BHC's price experiences larger fluctuations and is considered to be riskier than VTRS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BHCVTRSDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.32%

7.88%

+3.44%

Volatility (6M)

Calculated over the trailing 6-month period

29.09%

23.71%

+5.38%

Volatility (1Y)

Calculated over the trailing 1-year period

48.22%

32.45%

+15.77%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

60.60%

33.41%

+27.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

59.82%

33.88%

+25.94%

Dividends

BHC vs. VTRS - Dividend Comparison

BHC has not paid dividends to shareholders, while VTRS's dividend yield for the trailing twelve months is around 3.12%.


PositionTTM20252024202320222021
BHC
Bausch Health Companies Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
VTRS
Viatris Inc.
3.12%3.86%3.86%4.43%4.31%2.44%

Financials

BHC vs. VTRS - Financials Comparison

This section allows you to compare key financial metrics between Bausch Health Companies Inc. and Viatris Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B2.50B3.00B3.50B4.00B4.50B20222023202420252026
2.50B
3.52B
(BHC) Total Revenue
(VTRS) Total Revenue
Values in USD except per share items

BHC vs. VTRS - Profitability Comparison

The chart below illustrates the profitability comparison between Bausch Health Companies Inc. and Viatris Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
99.3%
32.9%
Portfolio components
BHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported a gross profit of 2.48B and revenue of 2.50B. Therefore, the gross margin over that period was 99.3%.

VTRS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Viatris Inc. reported a gross profit of 1.16B and revenue of 3.52B. Therefore, the gross margin over that period was 32.9%.

BHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported an operating income of -950.00M and revenue of 2.50B, resulting in an operating margin of -38.0%.

VTRS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Viatris Inc. reported an operating income of -79.70M and revenue of 3.52B, resulting in an operating margin of -2.3%.

BHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bausch Health Companies Inc. reported a net income of -1.42B and revenue of 2.50B, resulting in a net margin of -56.9%.

VTRS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Viatris Inc. reported a net income of 176.40M and revenue of 3.52B, resulting in a net margin of 5.0%.


Frequently Asked Questions


BHC and VTRS have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BHC has higher volatility (11.32%) compared to VTRS (7.88%). In terms of maximum drawdown, BHC dropped -98.35% vs VTRS's -54.33%.

VTRS currently has the higher Sharpe Ratio (2.49 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BHC and VTRS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer